Guido BocciGuido Bocci, MD PhD, is currently a Full Professor of Pharmacology at the University of Pisa. He is an European Certified Pharmacologist (EuCP). He maintains relevant international collaborations with various groups in Europe and North America. His iternational experience is closely related to the 3-year post-doctoral fellowship at the University of Toronto in the Kerbel’s Laboratory, with whom he continued to work in the following decades on numerous projects. He has been a PI of various projects granted by AIRC, ITT and foundations. He is in the editorial board of various journals, associate editor of Frontiers in Oncology, Frontiers in Pharmacology and regional editor of Clinical Cancer Drugs. He has been a grant reviewer for UK association for Cancer Research, South Plains Foundation (USA), French National Cancer Institute (France), Genesis Oncology Trust (New Zealand), Innsbruck Medical University (Austria), United States-Israel Binational Science Foundation and The German Israeli Foundation. Prof. Bocci is author of 4 national and 3 international patents, he has published 174 articles on international journals, 18 chapters on international and national books, and 1 international book as an editor on metronomic chemotherapy. The main research activity of Prof. Bocci has been focused on antineoplastic chemotherapy and antiangiogenic research, including both in vitro and in vivo experimental settings, and clinical pharmacology of chemotherapeutic drugs and antiangiogenic therapies. He has been deeply involved in the birth and development of metronomic chemotherapy concept in both pre-clinical and clinical trials. Read More Read Less